While traditional breast cancer screening saves lives, its methods often involve discomfort,
In the intricate and often relentless world of oncology, a recent discovery has illuminated a
A groundbreaking artificial intelligence method offers a profound new capability in cardiovascular diagnostics, enabling clinicians to identify high-risk fatty deposits within coronary arteries with unprecedented accuracy. This innovative system, developed by a dedicated research team from the
The journey through pediatric cancer treatment is a formidable one, marked not only by rigorous medical procedures but also by the often-unseen burdens of persistent pain, anxiety, and profound emotional distress. For countless children and their families, these psychological challenges are a daily
The ability to precisely visualize and manipulate molecular machinery inside living cells has long
A groundbreaking study published in the journal Genes has fundamentally altered the scientific
The biopharmaceutical sector is entering a new era. After last year's market disruptions, the industry faces a harsh truth: scientific breakthroughs alone are no longer enough to keep ahead of the…
By 2030, the tissue-engineering market is projected to exceed $32.45 billion , reflecting a
The landscape of rare disease drug development is littered with clinical failures. For every
Major policy changes are colliding with the complex economics of drug development. For B2B
Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is
Ivan Kairatov is a leading expert in biopharmaceutical innovation with a distinguished career in research and development, specializing in the intersection of artificial intelligence and synthetic biology. As a key contributor to the development of high-throughput protein engineering frameworks, he
The clinical obsession with GLP-1 receptor agonists has finally hit a biological wall where the
The global escalation of Type 2 Diabetes Mellitus has fundamentally transformed how medical
